Nexien BioPharma, Inc. (NXEN)

Market Cap	7.08K -98.2%
Revenue (ttm)	n/a
Net Income	-188.08K
EPS	-0.00
Shares Out	70.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,000
Open	0.0018
Previous Close	0.0001
Day's Range	0.0001 - 0.0018
52-Week Range	0.0001 - 0.0129
Beta	-0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About Nexien BioPharma

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Richard Greenberg
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NXEN

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 25, 2026

Data Sources Report a data error